Basel, 6 December 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced its plans to launch the SARS-CoV-2 & Flu A/B Rapid Antigen Test for professional use in markets accepting the CE Mark by the ...

Rapid antigen tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are effective tools for the diagnosis of acute infection, particularly when used serially. 1 The percentage of ...

In Germany, the activity of acute respiratory diseases is at a higher level than usual for this time of year because of rhinoviruses and SARS-CoV-2, according to the Robert Koch Institute, Germany. If ...

In a study involving nearly 1,000 patients seen at the Baltimore Convention Center Field Hospital (BCCFH) during a five-month period in 2022 - researchers at Johns Hopkins Medicine, the University of ...

More than two years after the World Health Organization (WHO) declared an end to the emergency phase of the Covid-19 pandemic, the virus continues to circulate globally. While current data suggest ...

Here’s what we know so far about the omicron variant. PREVIOUS REPORTING: Earlier this month, the White House announced that it would invest $1 billion to make more at-home COVID-19 tests available to ...

The World Health Organization (WHO) said on December 24, 2025, that it has prequalified two rapid antigen diagnostic tests (Ag-RDTs) for SARS-CoV-2, the virus that causes COVID-19. According to WHO, ...

Nathaniel Hafer receives funding from the National Institutes of Health and the National Science Foundation. Anuradha Rao receives funding from the National Institute of Biomedical Imaging and ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...